表紙
市場調査レポート

変性脊椎すべり症:世界の治験レビュー

Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 306659
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
変性脊椎すべり症:世界の治験レビュー Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014
出版日: 2014年06月20日 ページ情報: 英文 70 Pages
概要

当レポートでは、変性脊椎すべり症に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

目次

イントロダクション

  • 変性脊椎すべり症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州上位5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国における治験件数:中枢神経系治験に対する変性脊椎すべり症治験件数比率

G7諸国における治験件数:フェーズ(相)別

G7諸国における治験件数:進捗状況別

治験件数:フェーズ(相)別

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Mesoblast Limited
    • Zimmer Holdings, Inc.
    • Olympus Biotech Corporation
    • Northern Orthopaedic Division, Denmark
  • 代表的な研究機関病院の治験の概要
    • Walsh University
    • Zahedan University of Medical Sciences
    • Jyvaskyla Central Hospital
    • University Children Hospital Homburg
    • Mayo Clinic
    • University Medical Centre Ljubljana
    • Dartmouth-Hitchcock Medical Center
    • University Hospital, Bordeaux
    • UMC Utrecht Holding BV
    • Leiden University Medical Center

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2207CTIDB

GlobalData's clinical trial report, "Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2014" provides data on the Degenerative Spondylolisthesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Degenerative Spondylolisthesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Degenerative Spondylolisthesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Degenerative Spondylolisthesis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Degenerative Spondylolisthesis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Degenerative Spondylolisthesis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Degenerative Spondylolisthesis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Mesoblast Limited
      • Clinical Trial Overview of Mesoblast Limited
      • Zimmer Holdings, Inc.
      • Clinical Trial Overview of Zimmer Holdings, Inc.
      • Olympus Biotech Corporation
      • Clinical Trial Overview of Olympus Biotech Corporation
      • Northern Orthopaedic Division, Denmark
      • Clinical Trial Overview of Northern Orthopaedic Division, Denmark
    • Clinical Trial Overview of Top Institutes / Government
      • Walsh University
      • Clinical Trial Overview of Walsh University
      • Zahedan University of Medical Sciences
      • Clinical Trial Overview of Zahedan University of Medical Sciences
      • Jyvaskyla Central Hospital
      • Clinical Trial Overview of Jyvaskyla Central Hospital
      • University Children Hospital Homburg
      • Clinical Trial Overview of University Children Hospital Homburg
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • University Medical Centre Ljubljana
      • Clinical Trial Overview of University Medical Centre Ljubljana
      • Dartmouth-Hitchcock Medical Center
      • Clinical Trial Overview of Dartmouth-Hitchcock Medical Center
      • University Hospital, Bordeaux
      • Clinical Trial Overview of University Hospital, Bordeaux
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Degenerative Spondylolisthesis to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Degenerative Spondylolisthesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Degenerative Spondylolisthesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Degenerative Spondylolisthesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mesoblast Limited, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zimmer Holdings, Inc., 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Olympus Biotech Corporation, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Northern Orthopaedic Division, Denmark, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Walsh University, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zahedan University of Medical Sciences, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Jyvaskyla Central Hospital, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Children Hospital Homburg, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Centre Ljubljana, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014*

List of Figures

  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Degenerative Spondylolisthesis to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Degenerative Spondylolisthesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Degenerative Spondylolisthesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Degenerative Spondylolisthesis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Degenerative Spondylolisthesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Degenerative Spondylolisthesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • GlobalData Methodology
Back to Top